TGF-β1 signaling is associated with the regulation of malignancy initiation, progression, and metastasis in mammary carcinoma, pancreatic cancer, glioblastoma, prostate carcinoma, and hepatocellular carcinoma20. This evidence concerns the gene TGFB1 and prostate carcinoma.